Key result
Familial combined hyperlipidemia is a clinically relevant polygenic disorder primarily affecting triglyceride metabolism that significantly increases cardiovascular risk and is closely associated with insulin resistance.
Why the study?
Although familial combined hyperlipidemia (FCHL) was first described as a multiple-type hyperlipidemia in pedigrees with premature myocardial infarction, what actually defines FCHL remains questioned.
Answers are grounded in this paper and cite their sources.
This review reconceptualizes Familial Combined Hyperlipidemia as a polygenic rather than an autosomal dominant disorder, providing a new pathophysiological model for clinical guidance.
PURPOSE OF REVIEW: Familial combined hyperlipidemia (FCHL) was first described by Goldstein and co-workers in 1973 as a multiple-type hyperlipidemia in pedigrees with premature myocardial infarction. However, it can be questioned what actually defines FCHL. RECENT FINDINGS: Although initially regarded as an autosomal dominant disorder, quantitative trait linkage analyses have revealed multiple genes that are associated with the FCHL phenotype. With the advent of genome-wide association studies and next generation sequencing it has been confirmed that FCHL is a polygenic disorder and the associated gene variants, mostly with a triglyceride-raising effect, are not unique to FCHL. Furthermore, epidemiological studies have demonstrated that the multiple-type hyperlipidemia is also not specifically confined to FCHL. This review provides a historical overview of the metabolic and genetic abnormalities that characterize FCHL. Integration of these findings with recent population-based, genetic studies results in a new pathophysiological concept of FCHL. This model provides practical guidance on how to approach an individual patient with an 'FCHL phenotype'.
No takes yet. Share an insight, caveat, or question.
Brouwers et al. (2025) conducted a review in Familial Combined Hyperlipidemia (FCHL). Familial combined hyperlipidemia is a clinically relevant polygenic disorder primarily affecting triglyceride metabolism that significantly increases cardiovascular risk and is closely associated with insulin resistance.
Synapse has enriched 10 related papers. Consider them for comparative context: